LIMBER UniLeg: Rapid, On-demand, and Scaled-up Manufacturing of Customized Transtibial Prosthetic Legs for Amputees
2 other identifiers
interventional
30
1 country
2
Brief Summary
The LIMBER UniLeg, a 3D printed single-piece transtibial prosthetic limb, is sufficiently equivalent to traditional passive prosthetic limbs (no motors or sensors), while reducing the cost and time of manufacturing and enabling global reach through the use of digital technologies to solve the worldwide prosthetic accessibility crisis. This is a single-site, Phase I, Clinical Research Study to test the effectiveness and safety of the LIMBER UniLeg. One study group of 30 participants involved for two months using a non-inferiority design in which the participant will be assessed using their normal device (1 month) and the study device (1 month).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 20, 2023
CompletedFirst Submitted
Initial submission to the registry
October 11, 2024
CompletedFirst Posted
Study publicly available on registry
October 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2026
ExpectedNovember 26, 2024
November 1, 2024
1.9 years
October 11, 2024
November 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Mobility - 6min walk
Measure total distance for a timed six-min walk test for both the Limber UniLeg vs. existing prosthetic devices.
Baseline, 4weeks, 8 weeks
Mobility - Timed-Up-and-Go
Measure time for the timed up and go (TUG) test for both the Limber UniLeg vs. existing prosthetic devices.
Baseline, 4weeks, 8 weeks
Mobility--25 foot walk
Time to cover 25 feet walking at a normal speed
All visits (Baseline, 4 weeks, 8 weeks)
Secondary Outcomes (6)
Quality of Care - Gait Symmetry
Baseline, 4weeks, 8 weeks
Quality of Care - Perceived Balance Confidence_Limits of Stability
Baseline, 4weeks, 8 weeks
Quality of Care - Perceived Balance Confidence_Adaptation Test
Baseline, 4weeks, 8 weeks
Quality of Care - Perceived Balance Confidence_Motor Control
Baseline, 4weeks, 8 weeks
Quality of Care - Utilization--At-home movement
Baseline-4weeks, 4weeks-8weeks
- +1 more secondary outcomes
Other Outcomes (2)
Clinical Outcome - Pain
Baseline, 4weeks, 8 weeks
Clinical Outcome - Quality of Life-European Quality of Life 5-Dimension 5-Level questionnaire
Baseline, 4weeks, 8 weeks
Study Arms (1)
Intervention
EXPERIMENTALParticipants will be involved for two months using a non-inferiority design in which the participant will be assessed using their normal device (1 month) and the study device (1 month).
Interventions
Participants will be involved for two months using a non-inferiority design in which the participant will be assessed using their normal device (1 month) and the study device (1 month).
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent form.
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Persons, aged 18 to 75
- In good general health as determined by clinical site monitor
- Weight \< 125kg
- Are not diabetic (self reported)
- Be a unilateral transtibial amputee of more than 1 year since amputation
- Have an existing prosthetic device(s) that does not use sensors or motors (is passive)
- Live in the Southern California region (within 50 miles of UCSD)
- Has sufficient sensation in residual limb as tested by the clinical site monitor
- Agreement to adhere to Lifestyle Considerations throughout study duration 11a. Use the testing device (EPD or UniLeg) only during the testing periods. 11b. Walk at least 14,000 steps per week (average of 1 mile per day). 11c. Maintain a similar diet and activity level throughout study duration (no abrupt changes of weight, activity, etc.)
You may not qualify if:
- Not currently using a prosthetic device
- Prosthetic device with active motors, sensors, etc.
- Pregnancy (due to fall risk)
- Diabetic (due to poor limb sensation), self reported
- No under 18 (due to inability to consent)
- No over 75 (due to fall risk)
- Poor proprioception or sensation at the residual limb
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of California San Diego
La Jolla, California, 92093, United States
Limber Prosthetics & Orthotics Inc
San Diego, California, 92111, United States
Related Publications (20)
Holm, S. A simple sequentially rejective multiple test procedure. Scandinavian journal of statistics, 6(2):65-70, 1979.
BACKGROUNDEfron, B. and Tibshirani, R.J. An Introduction to the Bootstrap, Springer, New York, NY, 1993.
BACKGROUNDUS Department of Health and Human Services C for DC and P. Assessment Timed Up and Go (TUG).; 2017. Accessed June 12, 2018
BACKGROUNDSions JM, Beisheim EH, Manal TJ, Smith SC, Horne JR, Sarlo FB. Differences in Physical Performance Measures Among Patients With Unilateral Lower-Limb Amputations Classified as Functional Level K3 Versus K4. Arch Phys Med Rehabil. 2018 Jul;99(7):1333-1341. doi: 10.1016/j.apmr.2017.12.033. Epub 2018 Feb 1.
PMID: 29410114BACKGROUNDReid L, Thomson P, Besemann M, Dudek N. Going places: Does the two-minute walk test predict the six-minute walk test in lower extremity amputees? J Rehabil Med. 2015 Mar;47(3):256-61. doi: 10.2340/16501977-1916.
PMID: 25588644BACKGROUNDDite W, Connor HJ, Curtis HC. Clinical identification of multiple fall risk early after unilateral transtibial amputation. Arch Phys Med Rehabil. 2007 Jan;88(1):109-14. doi: 10.1016/j.apmr.2006.10.015.
PMID: 17207685BACKGROUNDMcCaffrey M, Beebe A. Managing your patients' adverse reactions to narcotics. Nursing. 1989 Oct;19(10):166-8. No abstract available.
PMID: 2586868BACKGROUNDWilliamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005 Aug;14(7):798-804. doi: 10.1111/j.1365-2702.2005.01121.x.
PMID: 16000093BACKGROUNDHerdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
PMID: 21479777BACKGROUNDHeil DP, Brage S, Rothney MP. Modeling physical activity outcomes from wearable monitors. Med Sci Sports Exerc. 2012 Jan;44(1 Suppl 1):S50-60. doi: 10.1249/MSS.0b013e3182399dcc.
PMID: 22157775BACKGROUNDBassett DR Jr, Rowlands A, Trost SG. Calibration and validation of wearable monitors. Med Sci Sports Exerc. 2012 Jan;44(1 Suppl 1):S32-8. doi: 10.1249/MSS.0b013e3182399cf7.
PMID: 22157772BACKGROUNDFreedson P, Bowles HR, Troiano R, Haskell W. Assessment of physical activity using wearable monitors: recommendations for monitor calibration and use in the field. Med Sci Sports Exerc. 2012 Jan;44(1 Suppl 1):S1-4. doi: 10.1249/MSS.0b013e3182399b7e.
PMID: 22157769BACKGROUNDRostagno C, Gensini GF. Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure. Intern Emerg Med. 2008 Sep;3(3):205-12. doi: 10.1007/s11739-008-0130-6. Epub 2008 Feb 26.
PMID: 18299800BACKGROUNDSolway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001 Jan;119(1):256-70. doi: 10.1378/chest.119.1.256.
PMID: 11157613BACKGROUNDBartels B, de Groot JF, Terwee CB. The six-minute walk test in chronic pediatric conditions: a systematic review of measurement properties. Phys Ther. 2013 Apr;93(4):529-41. doi: 10.2522/ptj.20120210. Epub 2012 Nov 15.
PMID: 23162042BACKGROUNDBui KL, Nyberg A, Maltais F, Saey D. Functional Tests in Chronic Obstructive Pulmonary Disease, Part 1: Clinical Relevance and Links to the International Classification of Functioning, Disability, and Health. Ann Am Thorac Soc. 2017 May;14(5):778-784. doi: 10.1513/AnnalsATS.201609-733AS.
PMID: 28244799BACKGROUNDATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available.
PMID: 12091180BACKGROUNDSprint G, Cook DJ, Weeks DL. Toward Automating Clinical Assessments: A Survey of the Timed Up and Go. IEEE Rev Biomed Eng. 2015;8:64-77. doi: 10.1109/RBME.2015.2390646. Epub 2015 Jan 12.
PMID: 25594979BACKGROUNDBarry E, Galvin R, Keogh C, Horgan F, Fahey T. Is the Timed Up and Go test a useful predictor of risk of falls in community dwelling older adults: a systematic review and meta-analysis. BMC Geriatr. 2014 Feb 1;14:14. doi: 10.1186/1471-2318-14-14.
PMID: 24484314BACKGROUNDSchoene D, Wu SM, Mikolaizak AS, Menant JC, Smith ST, Delbaere K, Lord SR. Discriminative ability and predictive validity of the timed up and go test in identifying older people who fall: systematic review and meta-analysis. J Am Geriatr Soc. 2013 Feb;61(2):202-8. doi: 10.1111/jgs.12106. Epub 2013 Jan 25.
PMID: 23350947BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Herb Barrack, CPO
LIMBER Prosthetics & Orthotics Inc
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2024
First Posted
October 18, 2024
Study Start
December 20, 2023
Primary Completion
October 31, 2025
Study Completion (Estimated)
October 31, 2026
Last Updated
November 26, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Demographic and baseline outcomes will be presented using summary statistics. No individual data will be provided.